Javascript must be enabled to continue!
A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape
View through CrossRef
Abstract
Introduction
Although e-cigarettes are not a federally approved tobacco cessation aid in the United States, many smokers use them to quit or cut down on smoking. Tailored behavioral support could improve rates of complete smoking cessation for those individuals.
Aims and Methods
A novel behavioral treatment to help dual cigarette and e-cigarette users quit smoking was tested in a randomized pilot with a state tobacco quitline. Ninety-six dual users of cigarettes and e-cigarettes were recruited from incoming state quitline callers and randomized to receive enhanced e-cigarette coaching (EEC) or quitline treatment as usual (TAU) to examine EEC feasibility and acceptability. Outcomes at 3 months were treatment satisfaction, engagement, beliefs, and smoking cessation. This pilot was not powered to detect differences in quit rates.
Results
Sixty-nine percent responded to the 3-month survey. EEC treatment satisfaction was noninferior to TAU: 93.8% (30/32) of EEC and 73.5% (25/34) of TAU reported being “very satisfied” or “satisfied” with treatment, respectively. EEC participants completed more coaching calls than TAU (M = 3.4 vs. M = 2.7, p = .03), and the majority in both groups elected to receive nicotine replacement therapy (EEC: 100%, TAU: 94%, p = .24). With missing data imputed as smoking, intent-to-treat 7-day point prevalence smoking abstinence rates were 41.3% (19/46) for EEC and 28.0% (14/50) for TAU (p = .20).
Conclusions
The EEC quitline intervention for dual cigarette and e-cigarette users demonstrated high levels of treatment satisfaction and engagement. This pilot was not powered to detect significant differences in smoking cessation; however, cessation rates were promising and warrant evaluation in a fully powered trial.
Implications
If this scalable behavioral treatment to help dual cigarette and e-cigarette users quit smoking proves to be effective in a larger trial, quitlines could implement this harm reduction approach to improve outcomes for callers who already use e-cigarettes and are planning to use them while quitting smoking.
Title: A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape
Description:
Abstract
Introduction
Although e-cigarettes are not a federally approved tobacco cessation aid in the United States, many smokers use them to quit or cut down on smoking.
Tailored behavioral support could improve rates of complete smoking cessation for those individuals.
Aims and Methods
A novel behavioral treatment to help dual cigarette and e-cigarette users quit smoking was tested in a randomized pilot with a state tobacco quitline.
Ninety-six dual users of cigarettes and e-cigarettes were recruited from incoming state quitline callers and randomized to receive enhanced e-cigarette coaching (EEC) or quitline treatment as usual (TAU) to examine EEC feasibility and acceptability.
Outcomes at 3 months were treatment satisfaction, engagement, beliefs, and smoking cessation.
This pilot was not powered to detect differences in quit rates.
Results
Sixty-nine percent responded to the 3-month survey.
EEC treatment satisfaction was noninferior to TAU: 93.
8% (30/32) of EEC and 73.
5% (25/34) of TAU reported being “very satisfied” or “satisfied” with treatment, respectively.
EEC participants completed more coaching calls than TAU (M = 3.
4 vs.
M = 2.
7, p = .
03), and the majority in both groups elected to receive nicotine replacement therapy (EEC: 100%, TAU: 94%, p = .
24).
With missing data imputed as smoking, intent-to-treat 7-day point prevalence smoking abstinence rates were 41.
3% (19/46) for EEC and 28.
0% (14/50) for TAU (p = .
20).
Conclusions
The EEC quitline intervention for dual cigarette and e-cigarette users demonstrated high levels of treatment satisfaction and engagement.
This pilot was not powered to detect significant differences in smoking cessation; however, cessation rates were promising and warrant evaluation in a fully powered trial.
Implications
If this scalable behavioral treatment to help dual cigarette and e-cigarette users quit smoking proves to be effective in a larger trial, quitlines could implement this harm reduction approach to improve outcomes for callers who already use e-cigarettes and are planning to use them while quitting smoking.
Related Results
Scottish smoke‐free legislation and trends in smoking cessation
Scottish smoke‐free legislation and trends in smoking cessation
ABSTRACTAim To investigate trends in smoking cessation before and after the introduction of Scottish smoke‐free legislation and to assess the perceived influence of the legislatio...
Biochemical parameters and oral fluid microcrystallization in young patients who use a vape device
Biochemical parameters and oral fluid microcrystallization in young patients who use a vape device
The study aims s are researching the negative effect of nicotine-containing vapes on physical and chemical parameters of oral fluid and morphotyping of dried oral fluid drop among ...
Implementing smoking cessation in routine primary care—a qualitative study
Implementing smoking cessation in routine primary care—a qualitative study
BackgroundThe use of digital tools has been proposed as a solution to some of the challenges of providing preventative services in primary care. Although there is a general accepta...
Health Promotion Model Not Smoking among Adolescents: A Path Analysis Evidence from Indonesia
Health Promotion Model Not Smoking among Adolescents: A Path Analysis Evidence from Indonesia
<p>Smoking behavior is a threat to public health. This study identified factors that influence non-smoking behavior among adolescents. The aim is to determine the effect of m...
Approaches to Smoking Cessation
Approaches to Smoking Cessation
Smoking cessation is a critical public health issue. Smoking cessation techniques are essential in reducing the burden of tobacco-related diseases and deaths. Medical practitioners...
Abstract 5042: Using a statewide collaborative approach to improve tobacco cessation referral rates for cancer patients
Abstract 5042: Using a statewide collaborative approach to improve tobacco cessation referral rates for cancer patients
Abstract
Purpose:
Though tobacco use by cancer patients is associated with poor therapeutic outcomes, most oncologists do not regularly provide tobacc...
The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials
The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials
Background Pharmacotherapies are widely used for smoking cessation.
However, their effect on smoking cessation for people with alcohol
dependence remains unclear. Objective This st...
Mobile Phone–Based Smoking-Cessation Intervention for Patients Undergoing Elective Surgery: Protocol for a Randomized Controlled Trial (Preprint)
Mobile Phone–Based Smoking-Cessation Intervention for Patients Undergoing Elective Surgery: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND
Several large studies have shown that the risk of cardiovascular, respiratory, and wound-healing complications (including death) within 30 days o...

